Related Experiment Videos
Complications of post-chemotherapy retroperitoneal lymph node dissection
J Baniel1, R S Foster, R G Rowland
1Department of Urology, Indiana University Medical Center, Indianapolis.
The Journal of Urology
|March 1, 1995
Summary
Surgical complications occurred in 20.7% of patients undergoing retroperitoneal lymphadenectomy for advanced testis cancer post-chemotherapy. Pulmonary issues were most common, highlighting the need for careful perioperative management in these complex cases.
Area of Science:
- Oncology
- Surgical Oncology
- Pulmonology
Background:
- Testis cancer often requires retroperitoneal lymphadenectomy (RPL) after chemotherapy for advanced stages.
- Patients undergoing RPL post-chemotherapy present unique challenges due to residual disease and treatment effects.
- Understanding surgical morbidity is crucial for optimizing patient outcomes.
Purpose of the Study:
- To review the surgical morbidity and mortality rates associated with lymphadenectomy in patients with clinical stages II and III testis cancer following primary chemotherapy.
- To identify specific complications and risk factors in this patient population.
- To provide insights into perioperative management strategies.
Main Methods:
- Retrospective review of 603 patients who underwent lymphadenectomy after primary chemotherapy for testis cancer (1982-1992).
- Analysis of complication rates, types of complications, and mortality.
- Comparison with primary retroperitoneal lymphadenectomy in fit patients.
Main Results:
- Overall morbidity rate was 20.7% (144 complications in 125 patients).
- Operative mortality was 0.8% (5 deaths).
- Pulmonary complications, including adult respiratory distress syndrome, were the most frequent severe morbidity, linked to bleomycin toxicity and large tumor burden.
Conclusions:
- Perioperative management for post-chemotherapy RPL differs significantly from primary RPL.
- Large disease volume, post-chemotherapy desmoplastic reaction, and extensive dissection increase complication risk.
- Careful management of pulmonary status and fluid balance is essential to minimize bleomycin-related morbidity.